{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:12:04Z","timestamp":1780459924647,"version":"3.54.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Medullary thyroid carcinoma (MTC) is a malignancy with a high mortality rate and a wide age range. However, there are relatively few studies on the relationship between age and all-cause mortality in patients with MTC. As one of the important factors influencing cancer prognosis, the association between age and all-cause mortality in MTC patients needs to be further investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to investigate the relationship between age and all-cause mortality in MTC patients, especially whether there is an inverse L-shaped curve relationship, in order to provide new insights for clinical management and prognostic assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A detailed retrospective cohort analysis of 1291 MTC patients diagnosed between 2000 and 2021 was included in this study using the Surveillance, Epidemiology, and End Results (SEER) database. Cox regression modelling, curve fitting, Kaplan-Meier (KM) survival curves and subgroup analyses were used to assess the association between age and all-cause mortality in MTC patients. Potential confounders, including patient sex, race, Summary stage, surgery, Lymph.node.dissection, tumour size and lymph node metastasis (LNM), were rigorously controlled.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The risk of all-cause mortality in MTC patients increased by 6% per 1-year increase in age (hazard ratio HR=1.06, 95% confidence interval CI: 1.05-1.06, p&amp;lt;0.001). Further analysis revealed a significant inverse L-shaped relationship between age and all-cause mortality in MTC patients. Specifically, before the age of 50 years, the hazard ratio increased slowly with age (HR=1.024, 95% CI: 0.991-1.059) and the difference was not statistically significant (p=0.1616). After the age of 50 years, the hazard ratio accelerated with increasing age (HR=1.066, 95% CI: 1.051-1.081) and the difference was statistically significant (p&amp;lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study confirm that there is an inverse L-shaped relationship between age and all-cause mortality in MTC patients. The risk of all-cause mortality in MTC patients increased significantly with age after age &amp;gt;50 years. This finding provides new insights into understanding the complex relationship between age and all-cause mortality in MTC, which may help inform clinical management and prognostic assessment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1574985","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:45Z","timestamp":1749528645000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["All-cause mortality in patients with medullary thyroid carcinoma of different ages: an inverse L-curve analysis study"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiahua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096258716231026063704","article-title":"LINC00887 acts as an enhancer RNA to promote medullary thyroid carcinoma progression by binding with FOXQ1","volume":"24","author":"Liu","year":"2024","journal-title":"Curr Cancer Drug Targets"},{"key":"B2","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00006231-200409000-00006","article-title":"The British Thyroid Association guidelines for the management of thyroid cancer in adults","volume":"25","author":"Watkinson","year":"2004","journal-title":"Nucl Med Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.5539","article-title":"Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines","volume":"26","author":"Thomas","year":"2019","journal-title":"Curr Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194865","article-title":"Molecular basis and natural history of medullary thyroid cancer: it is (Almost) all in the RET","volume":"15","author":"Sahakian","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20231110-01059","article-title":"Progress and controversy on the extent of surgery for medullary thyroid carcinoma based on calcitonin levels","volume":"104","author":"Xian","year":"2024","journal-title":"Zhonghua yi xue za zhi"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0157","article-title":"Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study","volume":"7","author":"Mathiesen","year":"2018","journal-title":"Endocr Connect"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001867","article-title":"A case report of multiple endocrine neoplasia type 2B","volume":"86","author":"Jahantab","year":"2024","journal-title":"Ann Med Surg (2012)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i15.2627","article-title":"C634Y mutation in RET-induced multiple endocrine neoplasia type 2A: A case report","volume":"12","author":"Zhang","year":"2024","journal-title":"World J Clin cases"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad013","article-title":"Medullary thyroid cancer: updates and challenges","volume":"44","author":"Gild","year":"2023","journal-title":"Endocr Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v107:9","article-title":"Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrc1836","article-title":"Pathogenetic mechanisms in thyroid follicular-cell neoplasia","volume":"6","author":"Kondo","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v50i2.5358","article-title":"Expression of miR-127, miR-154, and miR-183 in Medullary Thyroid Carcinoma Tumors","volume":"50","author":"Rahmani Samani","year":"2021","journal-title":"Iran J Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/CCO.0b013e32831ba0b3","article-title":"Medullary thyroid cancer: early detection and novel treatments","volume":"21","author":"Roman","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1210\/endrev\/bnad013","article-title":"Familial non-medullary thyroid carcinoma: clinico-pathological features, current knowledge and novelty regarding genetic risk factors","volume":"46","author":"Cirello","year":"2020","journal-title":"Minerva Endocrinol (Torino)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6507.20.03338-6","article-title":"Short-term mortality following surgical procedures for the diagnosis of pediatric brain tumors: outcome analysis in 5533 children from SEER, 2004-2011","volume":"17","author":"Hankinson","year":"2015","journal-title":"J Neurosurg Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0000000000000619","article-title":"Pediatric low-grade ganglioglioma: epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database","volume":"76","author":"Dudley","year":"2015","journal-title":"Neurosurg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-014-1628-6","article-title":"Pediatric choroid plexus tumors: epidemiology, treatments, and outcome analysis on 202 children from the SEER database","volume":"121","author":"Dudley","year":"2014","journal-title":"J Neurooncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3171\/2011.3.JNS101748","article-title":"Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute","volume":"115","author":"Cahill","year":"2011","journal-title":"Clin article J Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17849\/insm-48-1-1-19.1","article-title":"20-year comparative survival and mortality of cancer of the stomach by age, sex, race, stage, grade, cohort entry time-period, disease duration & Selected ICD-O-3 oncologic phenotypes: A systematic review of 157,258 cases for diagnosis years 1973-2014: (SEER*Stat 8.3.4)","volume":"48","author":"Milano","year":"2019","journal-title":"J Insur Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.17849\/insm-48-1-1-19.1","article-title":"NCI SEER public-use data: applications and limitations in oncology research","volume":"23","author":"Yu","year":"2009","journal-title":"Oncol (Williston Park)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"13310","DOI":"10.1038\/s41598-020-70439-7","article-title":"Comparison of pediatric and adult medullary thyroid carcinoma based on SEER program","volume":"10","author":"Zhao","year":"2020","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2022.11.005","article-title":"Age-associated remodeling of T cell immunity and metabolism","volume":"35","author":"Han","year":"2023","journal-title":"Cell Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression","volume":"20","author":"Fane","year":"2020","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1574985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:10:46Z","timestamp":1749528646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1574985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":24,"alternative-id":["10.3389\/fendo.2025.1574985"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1574985","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"article-number":"1574985"}}